Depressive Disorder, Major
Neurology·MeSH: Depressive Disorder
Prevalence
3062.9 / 100K
Incidence
3754.6 / 100K/yr
6 drugs in development·3 companies·7 clinical trials
Drug Pipeline by Phase
Phase 3(4)
Phase 2(1)
| Drug | Company |
|---|---|
| jnj-89495120 | GH Research PLC (GHRS) |
Phase 2/Phase 3(1)
| Drug | Company |
|---|---|
| mitizodone | SUNSHINE BIOPHARMA INC. (SBFM) |
Compare drugs
Frequently asked questions
How many drugs are in development for Depressive Disorder, Major?
BioSniper tracks 6 drugs in development for Depressive Disorder, Major across 3 companies.
How many clinical trials target Depressive Disorder, Major?
There are 7 clinical trials targeting Depressive Disorder, Major tracked by BioSniper.
What is the prevalence of Depressive Disorder, Major?
The estimated prevalence of Depressive Disorder, Major is approximately 3062.9 per 100,000 population.
Deep-dive into Depressive Disorder, Major
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis